Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Prevalence of Pediatric Masked Hypertension and Risk of Subclinical Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Published:2023-11 Issue:11 Volume:80 Page:2280-2292
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Chung Jason¹^ORCID,Robinson Cal²^ORCID,Sheffield Lauren³^ORCID,Paramanathan Prathayini⁴^ORCID,Yu Andrew⁵^ORCID,Ewusie Joycelyne⁶^ORCID,Sanger Stephanie⁷^ORCID,Mitsnefes Mark⁸^ORCID,Parekh Rulan S.⁹^ORCID,Sinha Manish D.¹⁰^ORCID,Rodrigues Myanca¹¹^ORCID,Thabane Lehana⁶¹²,Dionne Janis¹³^ORCID,Chanchlani Rahul¹⁴^ORCID

Affiliation:

1. Temerty Faculty of Medicine, University of Toronto, Ontario, Canada (J.C.).

2. Department of Pediatrics, Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada (C.R.).

3. Faculty of Sciences, McMaster University, Hamilton, Ontario, Canada (L.S.).

4. All Saints University College of Medicine, Kingstown, Saint Vincent and the Grenadines (P.P.).

5. Faculty of Science, University of Alberta, Edmonton, Canada (A.Y.).

6. Department of Health Research Methods, Evidence, and Impact, Research Institute - St Joseph’s Healthcare Hamilton, McMaster University, Ontario, Canada (J.E., L.T.).

7. Department of Health Sciences: Health Science Library, McMaster University, Hamilton, Ontario, Canada (S.S.).

8. Department of Pediatrics, Division of Nephrology, Cincinnati Children’s Hospital Medical Center, OH (M.M.).

9. Department of Pediatrics and Medicine, Division of Nephrology, The Hospital for Sick Children, University Health Network and University of Toronto, Ontario, Canada (R.S.P.).

10. Department of Paediatric Nephrology, King’s College London, Evelina London Childrens Hospital, United Kingdom (M.D.S.).

11. Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada (M.R.).

12. University of Johannesburg Faculty of Health Sciences, South Africa (L.T.).

13. Department of Pediatrics, Division of Nephrology, University of British Columbia, Vancouver, Canada (J.D.).

14. Department of Pediatrics, Division of Pediatric Nephrology, McMaster Children’s Hospital, McMaster University, Hamilton, Canada (R.C.).

Abstract

Masked hypertension (MH) occurs when office blood pressure is normal, but hypertension is confirmed using out-of-office blood pressure measures. Hypertension is a risk factor for subclinical cardiovascular outcomes, including left ventricular hypertrophy, increased left ventricular mass index, carotid intima media thickness, and pulse wave velocity. However, the risk factors for ambulatory blood pressure monitoring defined MH and its association with subclinical cardiovascular outcomes are unclear. A systematic literature search on 9 databases included English publications from 1974 to 2023. Pediatric MH prevalence was stratified by disease comorbidities and compared with the general pediatric population. We also compared the prevalence of left ventricular hypertrophy, and mean differences in left ventricular mass index, carotid intima media thickness, and pulse wave velocity between MH versus normotensive pediatric patients. Of 2199 screened studies, 136 studies (n=28 612; ages 4–25 years) were included. The prevalence of MH in the general pediatric population was 10.4% (95% CI, 8.00–12.80). Compared with the general pediatric population, the risk ratio (RR) of MH was significantly greater in children with coarctation of the aorta (RR, 1.91), solid-organ or stem-cell transplant (RR, 2.34), chronic kidney disease (RR, 2.44), and sickle cell disease (RR, 1.33). MH patients had increased risk of subclinical cardiovascular outcomes compared with normotensive patients, including higher left ventricular mass index (mean difference, 3.86 g/m 2.7 [95% CI, 2.51–5.22]), left ventricular hypertrophy (odds ratio, 2.44 [95% CI, 1.50–3.96]), and higher pulse wave velocity (mean difference, 0.30 m/s [95% CI, 0.14–0.45]). The prevalence of MH is significantly elevated among children with various comorbidities. Children with MH have evidence of subclinical cardiovascular outcomes, which increases their risk of long-term cardiovascular disease.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference74 articles.

1. Global Prevalence of Hypertension in Children

2. Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events

3. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents

4. Elevated Blood Pressure in Childhood or Adolescence and Cardiovascular Outcomes in Adulthood

5. Screening for Hypertension in Children and Adolescents to Prevent Cardiovascular Disease

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence Of Ambulatory Hypertension in Pediatric Kidney Transplant Recipients Using the New 2022 Ambulatory Blood Pressure Monitoring Guidelines;2024-07-18

2. Long-Term Cardiovascular Outcomes in Children and Adolescents With Hypertension;JAMA Pediatrics;2024-07-01

3. Investigation and management of young-onset hypertension: British and Irish hypertension society position statement;Journal of Human Hypertension;2024-06-28

4. Pediatric Blood Pressure and Cardiovascular Health in Adulthood;Current Hypertension Reports;2024-06-15

5. Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives;Hypertension Research;2024-05-29